South Texas Accelerated Research Therapeutics - Carolinas

Clinical research site in Myrtle Beach, South Carolina

Part of South Texas Accelerated Research Therapeutics

As of July 2026, 1 paid clinical trial is recruiting at South Texas Accelerated Research Therapeutics - Carolinas in Myrtle Beach, South Carolina. Active studies at this site focus on Metastatic Hormone-sensitive Prostate Cancer (mHSPC) alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at South Texas Accelerated Research Therapeutics - Carolinas (1)

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

for Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

8 locations incl. San Francisco

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT07140900·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Explore more

Paid clinical trials in Myrtle Beach, SC · South Carolina clinical trials

South Texas Accelerated Research Therapeutics - Carolinas

Recruiting clinical trials at South Texas Accelerated Research Therapeutics - Carolinas (1)

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

More research sites in Myrtle Beach

Explore more